GlassScriptPhysician profile
Vishnu A Patel
NPI 1265400865
$10,214.85
in general payments reported to CMS, 2019-2025
36 companies · $2,604 in 2025
The $2,604 reported for 2025 was more than what 80% of Pulmonary Disease providers received nationally (typical 2025 total: $500).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $793 · 2020: $1,191 · 2021: $1,054 · 2022: $1,145 · 2023: $1,631 · 2024: $1,796 · 2025: $2,604.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $5,930 · Education: $101.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $5,930.23 |
| Education | $101.01 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astrazeneca Pharmaceuticals LP | $2,951.31 | 2019-2025 | Fasenra, Breztri, Tezspire |
| Glaxosmithkline, LLC. | $1,807.89 | 2019-2025 | Trelegy Ellipta, Nucala, Arexvy |
| Boehringer Ingelheim Pharmaceuticals, INC. | $1,038.58 | 2019-2025 | Ofev, Spiriva Respimat, Stiolto Respimat |
| Jazz Pharmaceuticals INC. | $475.36 | 2020-2025 | |
| Takeda Pharmaceuticals U.S.A., INC. | $463.84 | 2020-2025 | Aralast, Glassia |
| Axsome Therapeutics, INC. | $360.17 | 2023-2025 | Sunosi |
| Baxter Healthcare | $324.85 | 2022-2025 | Hillrom - Vest System Model 105 Home Care, Hillrom - Life 2000 Ventilation System |
| Pulmonx Corporation | $322.06 | 2021-2024 | Zephyr Delivery Catheter, Pulmonx Chartis Tablet Console, Chartis Catheter |
| Mylan Specialty L.P. | $299.18 | 2019-2023 | Yupelri |
| Amgen INC. | $242.20 | 2023-2025 | Tezspire |
| Regeneron Healthcare Solutions, INC. | $206.63 | 2024-2025 | Dupixent |
| Inspire Medical Systems, INC. | $163.13 | 2022-2023 | Inspire |
| United Therapeutics Corporation | $157.02 | 2025 | Tyvaso |
| Genzyme Corporation | $155.86 | 2019-2025 | |
| Teva Pharmaceuticals USA, INC. | $115.20 | 2020-2022 |
Show all 36 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Philips North America LLC | $111.40 | 2020-2025 | Home Pi Undivided, Patient Interface Software |
| Verona Pharma, INC. | $108.20 | 2025 | Ohtuvayre |
| Harmony Biosciences LLC | $100.59 | 2020-2025 | |
| Allergan, INC. | $99.73 | 2019-2020 | |
| Sunovion Pharmaceuticals INC. | $94.14 | 2020-2021 | |
| Grifols USA, LLC | $72.28 | 2023-2024 | Prolastin-C Liquid |
| Abbvie INC. | $65.39 | 2021-2022 | |
| Viatris Specialty LLC | $63.54 | 2025 | Yupelri |
| Insmed, INC. | $60.72 | 2019-2025 | Arikayce |
| Actelion Pharmaceuticals US, INC. | $58.82 | 2025 | Opsynvi, Uptravi |
| Csl Behring | $51.76 | 2020 | |
| Shire North American Group INC | $50.45 | 2019 | |
| Avadel Cns Pharmaceuticals, LLC | $40.31 | 2025 | Lumryz |
| Merck Sharp & Dohme LLC | $32.94 | 2022-2023 | |
| Apria Healthcare LLC | $26.16 | 2021 | |
| Mallinckrodt Hospital Products INC. | $17.55 | 2021 | |
| Pfizer INC. | $17.48 | 2020 | |
| Tactile Systems Technology INC | $15.91 | 2024 | Entre Plus, Flexitouch Plus |
| Lilly USA, LLC | $15.44 | 2025 | Zepbound |
| Inogen, INC. | $15.02 | 2023 | Inogen One G5 Oxygen Concentrator - Bluetooth |
| Electromed, INC. | $13.74 | 2024 | Smartvest |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Vishnu Patel listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.